Nicolò Carrano

Nicolò Carrano

Auto-generated profile, based on publicly available information

Nicolò Carrano

Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”, University of Milan; Milan, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LFLuca Franchini
Luca Franchini
NCNicolò Carrano
Nicolò Carrano
MLMonica Di Luca
Monica Di Luca
FGFabrizio Gardoni
Fabrizio Gardoni
N-Methyl-d-Aspartate Receptors (NMDARs) are ionotropic glutamate-gated receptors. NMDARs are tetramers composed by several homologous subunits of GluN1-, GluN2-, or GluN3-type, leading to the existence in the central nervous system of a high variety of receptor subtypes with different pharmacological and signaling properties. NMDAR subunit composition is strictly regulated during development and by activity-dependent synaptic plasticity. Given the differences between GluN2 regulatory subunits of NMDAR in several functions, here we will focus on the synaptic pool of NMDARs containing the GluN2A subunit, addressing its role in both physiology and pathological synaptic plasticity as well as the contribution in these events of different types of GluN2A-interacting proteins.

1 September 2019 in iScience
Verified
Journal Article
Open access
LFLuca Franchini
Luca Franchini
JSJennifer Stanic
Jennifer Stanic
LPLuisa Ponzoni
Luisa Ponzoni
MMManuela Mellone
Manuela Mellone
NCNicolò Carrano
Nicolò Carrano
FGFabrizio Gardoni
Fabrizio Gardoni

30 July 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
MRMaria De Risi
Maria De Risi
GTGiulia Torromino
Giulia Torromino
MTMichele Tufano
Michele Tufano
SMStéphanie Moriceau
Stéphanie Moriceau
APAnnabella Pignataro
Annabella Pignataro
ELElvira De Leonibus
Elvira De Leonibus
Autophagy agonists have been proposed to slow down neurodegeneration. Spermidine, a polyamine that acts as an autophagy agonist, is currently under clinical trial for the treatment of age‐related memory decline. How Spermidine and other autophagy agonists regulate memory and synaptic plasticity is under investigation. We set up a novel mouse model of mild cognitive impairment (MCI), in which middle‐aged (12‐month‐old) mice exhibit impaired memory capacity, lysosomes engulfed with amyloid fibrils (β‐amyloid and α‐synuclein) and impaired task‐induced GluA1 hippocampal post‐translation modifications. Subchronic treatment with Spermidine as well as the autophagy agonist TAT‐Beclin 1 rescued memory capacity and GluA1 post‐translational modifications by favouring the autophagy/lysosomal‐mediated degradation of amyloid fibrils. These findings provide new mechanistic evidence on the therapeutic relevance of autophagy enhancers which, by improving the degradation of misfolded proteins, slow down age‐related memory decline.

1 July 2020 in Neurobiology of Disease
Verified
Journal Article
Open access
PMPetra Mazzocchetti
Petra Mazzocchetti
AMAndrea Mancini
Andrea Mancini
MSMiriam Sciaccaluga
Miriam Sciaccaluga
AMAlfredo Megaro
Alfredo Megaro
LBLaura Bellingacci
Laura Bellingacci
CCCinzia Costa
Cinzia Costa
Energy depletion caused by ischemic brain insults may result in persistent neuronal depolarization accompanied by hyper-stimulation of ionotropic glutamate receptors and excitotoxic phenomena, possibly leading to cell death. The use of glutamate receptor antagonists, such as the AMPARs antagonist Perampanel (PER), might be a pharmacological approach to counteract the excessive over-activation of glutamate receptors providing neuroprotective effects. Using electrophysiological and molecular analyses, we investigated the effect of PER against in vitro ischemia obtained by oxygen and glucose deprivation (OGD) in rat slices of two brain structures particularly sensitive to ischemic insults, the nucleus striatum and the hippocampus. We found that in these regions PER was able to avoid the OGD-induced neuronal suffering, at low doses not reducing basal excitatory synaptic transmission and not altering long-term potentiation (LTP) induction. Furthermore, in both the analysed regions, PER blocked a pathological form of LTP, namely ischemic LTP (iLTP). Finally, we hypothesized that the protective effect of PER against OGD was due to its capability to normalize the altered synaptic localization and function of AMPAR subunits, occuring after an ischemic insult. Taken together these findings support the idea that PER is a drug potentially effective to counteract ischemic damage.

8 May 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
NCNicolò Carrano
Nicolò Carrano
TSTanmoy Samaddar
Tanmoy Samaddar
EBElectra Brunialti
Electra Brunialti
LFLuca Franchini
Luca Franchini
EMElena Marcello
Elena Marcello
FGFabrizio Gardoni
Fabrizio Gardoni

11 March 2026 in The Journal of Physiology
Verified
Journal Article
Open access
HFHubert Fiumelli
Hubert Fiumelli
GHGabriel Herrera‐López
Gabriel Herrera‐López
FLFouad Lemtiri‐Chlieh
Fouad Lemtiri‐Chlieh
LMLorène Mottier
Lorène Mottier
JGJohn Girgis
John Girgis
PMPierre J. Magistretti
Pierre J. Magistretti
Astrocyte‐derived lactate, through the astrocyte–neuron lactate shuttle, fuels neuronal energy demands and acts as a signalling molecule promoting synaptic plasticity and memory consolidation. Lactate regulates neuronal excitability and expression of genes related to synaptic plasticity and neuroprotection, but the molecular mechanisms remain unclear. Using patch‐clamp recordings in cultured cortical neurons we found that lactate enhances NMDA receptor currents (I NMDAR ), increasing their amplitude and decay time constant. Not reproduced by HCAR1 agonists, this modulation depends on monocarboxylate transporters and lactate dehydrogenase, requiring lactate entry, metabolic conversion to pyruvate and NADH formation within neurons. Disruption of intracellular calcium dynamics or inhibition of Ca 2+ /calmodulin‐dependent protein kinase II (CaMKII) diminishes lactate's effects on I NMDAR . Two redox‐sensitive cysteine‐containing sequences in the intracellular C‐terminal domain of GluN2B subunit play a crucial role in the potentiation of NMDAR by lactate. Experiments in HEK cells demonstrate that functional CaMKII and GluN2B‐containing NMDARs are necessary for lactate's effects. Mutations in GluN2B, that disrupt either CaMKII binding or cysteine‐mediated redox regulation, abolish lactate's modulatory action. Immunoprecipitation experiments in neurons show that lactate promotes CaMKII‐GluN2B association, which is critical for increasing I NMDAR amplitude. Proximity ligation assays between GluN2B and PSD‐95 reveal that lactate induces GluN2B accumulation in dendritic spines, an effect a CaMKII inhibitor prevents. These findings elucidate a pathway whereby lactate enhances NMDAR function through metabolic conversion and redox‐sensitive interactions requiring CaMKII, linking astrocyte energy metabolism to synaptic modulation. image Key points: Astrocytes produce lactate, traditionally seen as an energy source, which also acts as a signalling molecule in the brain, influencing memory and synaptic plasticity by modulating NMDA receptor (NMDAR) function. Lactate enhances NMDAR responses specifically by increasing current amplitude through changes in cellular redox balance, which requires the entry of lactate into neurons and its conversion to pyruvate, producing NADH. Lactate‐induced potentiation of NMDARs depends on calcium signalling involving Ca 2 + /calmodulin‐dependent protein kinase II (CaMKII), which interacts directly with the GluN2B subunit of the receptor. Lactate strengthens the interaction between CaMKII and GluN2B through redox‐sensitive cysteine residues in GluN2B, facilitating synaptic localization of this complex and enhancing synaptic responses. These findings reveal a molecular pathway by which lactate, produced by astrocytes, can significantly influence neuronal activity and synaptic function, linking brain metabolism with learning and memory processes.